登士柏国际

UBS Group

UBS Maintains Buy Rating for DENTSPLY, Downgrades PT to $16

DENTSPLY's 15min Chart Triggers MACD Death Cross, KDJ Death Cross Signals

DENTSPLY

Mizuho Analyst Raises Price Target for Dentsply Sirona to $14.00

Mizuho Financial Group

安可资本

DENTSPLY: Mizuho Raises PT to $14 from $13, Maintains Neutral Rating

Mizuho Raises Dentsply Sirona PT to $14, Maintains Neutral Rating

Catalyst<ul> <li>Most analysts rate XRAY Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Bearish signals are obviously dominant (6 bearish vs 0 bullish) according to technical indicators.</li> <li>Fund flow analysis shows negative trends across all order size buckets.</li> <li>Technical indicators show that the market is in a weak state and we need to pay attention to the risk of decline.</li></ul>

Key Factors

Mizuho analyst Steven Valiquette raised XRAY's price target to $14.00 from $13.00 while maintaining a Neutral rating.

Recent Updates

XRAY News